Hydrocodone is a prescription opioid analgesic used to manage pain severe enough to require an opioid when alternative treatments are inadequate or not tolerated. It works mainly by binding to opioid receptors in the central nervous system, reducing the perception and emotional response to pain. Hydrocodone is available in different formulations, including immediate-release combination products with acetaminophen and extended-release hydrocodone products for severe, persistent pain. Because hydrocodone is a controlled opioid medicine, it carries important risks related to respiratory depression, misuse, dependence, overdose, and addiction. 

Important Warnings while taking Hydrocodone 

Hydrocodone can cause serious or life-threatening respiratory depression, particularly when treatment is started or the dose is increased. Excessive opioid effects can slow breathing and may lead to unconsciousness, coma, or death. The risk is particularly important when hydrocodone is combined with other medicines that depress the central nervous system.  

Hydrocodone carries a boxed warning for addiction, abuse, and misuse. Even when taken as prescribed, patients can develop physical dependence, and inappropriate use can result in overdose and death. Healthcare professionals generally assess the patient's risk before prescribing and continue monitoring during treatment.  

Combining hydrocodone with benzodiazepines, alcohol, sedatives, or other central nervous system depressants can cause profound sedation, respiratory depression, coma, and death. Such combinations require careful medical supervision.  

Some hydrocodone products contain acetaminophen, which can cause serious liver injury when excessive amounts are consumed. Patients taking combination hydrocodone-acetaminophen products should avoid taking additional acetaminophen-containing medicines unless instructed by a healthcare professional.  

Hydrocodone should not be stopped suddenly after prolonged use without medical advice because abrupt discontinuation can cause opioid withdrawal symptoms. Extended-release tablets must also be swallowed whole because crushing, chewing, dissolving, or otherwise altering them can result in rapid release of the drug and potentially fatal overdose.

Things to consider before Hydrocodone consumption 

• Allergy to hydrocodone or other opioids 
• Breathing problems or lung disease 
• Asthma or chronic obstructive pulmonary disease 
• Sleep apnea 
• Head injury or increased intracranial pressure 
• Liver disease 
• Kidney disease 
• History of opioid or substance misuse 
• Alcohol consumption 
• Depression or other mental health conditions 
• Pregnancy and breastfeeding 
• Other opioid medicines 
• Benzodiazepines and other sedatives 
• Other prescription medicines and supplements 
• Need to drive or operate machinery 

These considerations are important because hydrocodone can suppress breathing and cause sedation, making respiratory conditions, sleep apnea, and other factors that reduce breathing particularly important to discuss before treatment. Liver disease is especially relevant when hydrocodone is combined with acetaminophen, while kidney or liver impairment can affect medication handling and may require careful dose selection. A history of substance misuse or alcohol use can increase concerns about opioid-related harms.

Patients should disclose all medicines, particularly benzodiazepines, sedatives, other opioids, and medicines that affect CYP3A4, because interactions can increase hydrocodone exposure or respiratory depression. Pregnancy and breastfeeding also require medical discussion because opioids can affect the newborn and can pass into breast milk. Patients should also avoid driving or hazardous activities until they know how hydrocodone affects their alertness.

Application/Consumption 

Hydrocodone is taken orally, but the exact administration depends on the formulation prescribed. Immediate-release hydrocodone combination tablets are generally used for pain requiring opioid treatment. In contrast, extended-release hydrocodone is reserved for severe and persistent pain requiring continuous, around-the-clock opioid therapy.  

Patients should take hydrocodone exactly as prescribed and should never take a larger amount or take doses more frequently than directed. Extended-release tablets must be swallowed whole and should never be crushed, chewed, dissolved, or split because doing so can release a potentially fatal amount of hydrocodone at once.  

Patients taking hydrocodone-acetaminophen products should check all other medicines for acetaminophen. Combining several products containing acetaminophen can result in excessive daily intake and serious liver injury. 

Because hydrocodone can cause dizziness and drowsiness, patients should avoid driving or operating machinery until they know how the medicine affects them. Alcohol and other sedating medicines should not be combined with hydrocodone unless specifically directed by a healthcare professional. 

If hydrocodone has been used regularly for an extended period, discontinuation should generally involve gradual dose reduction under medical supervision rather than abrupt cessation.

Dosing information 

Hydrocodone dosing is highly individualized and depends on the specific formulation, severity of pain, previous opioid exposure, age, medical conditions, and response to treatment. 

The lowest effective opioid dose for the shortest appropriate duration is generally used. Dose increases require careful assessment because higher opioid exposure increases the risks of respiratory depression, sedation, overdose, and other adverse effects. 

Patients should never increase their hydrocodone dose independently. An overdose can cause extreme sleepiness, pinpoint pupils, slow or stopped breathing, unconsciousness, coma, and death and requires emergency medical attention.

Uses

Hydrocodone is used for: 

• Severe acute pain requiring opioid treatment 
• Severe persistent pain requiring continuous opioid therapy, when alternative treatments are inadequate 
• Pain that does not respond sufficiently to non-opioid treatment 
• Pain in patients who cannot tolerate appropriate alternative treatments 

Hydrocodone reduces pain by activating opioid receptors in the central nervous system. It can provide substantial analgesia, but because it also affects brain regions involved in breathing, alertness, and reward, treatment requires careful dosing and monitoring.

Hydrocodone side effects

Common side effects of hydrocodone can include constipation, nausea, vomiting, dizziness, drowsiness, lightheadedness, headache, and sedation. These effects may become more noticeable when treatment starts, or the dosage increases. 

Respiratory depression is one of the most serious adverse effects. Breathing can become dangerously slow or shallow, particularly after starting treatment, increasing the dose, or combining hydrocodone with alcohol, benzodiazepines, or other central nervous system depressants. Severe respiratory depression requires emergency medical attention.  

Hydrocodone can cause physical dependence and tolerance with repeated use. Physical dependence means withdrawal symptoms may occur if treatment is suddenly stopped. Withdrawal can include restlessness, sweating, muscle aches, anxiety, runny nose, abdominal cramps, diarrhea, and sleep disturbances. Medical supervision is recommended when reducing long-term opioid therapy. 

Hydrocodone can also cause constipation, which may become persistent during opioid treatment. Patients should discuss appropriate prevention and treatment of opioid-related constipation with their healthcare professional. 

Some patients may experience dizziness, confusion, impaired coordination, or excessive sedation. These effects can increase the risk of falls and accidents, particularly in older adults. 

Hydrocodone can interact with medicines that inhibit or induce CYP3A4, an enzyme involved in hydrocodone metabolism. CYP3A4 inhibitors can increase hydrocodone concentrations and potentially increase respiratory depression, while changes involving CYP3A4 inducers can also alter opioid exposure.  

Combining hydrocodone with benzodiazepines or other central nervous system depressants can substantially increase sedation and respiratory depression. Alcohol can produce similar additive effects and should be avoided unless specifically permitted by a healthcare professional.  

When hydrocodone is combined with acetaminophen, excessive acetaminophen exposure can cause severe liver injury. Patients should monitor the total amount of acetaminophen from every medicine they take. Current labeling notes that many cases of acetaminophen-related liver injury involve doses exceeding 4,000 mg per day and more than one acetaminophen-containing product.  

Long-term opioid treatment during pregnancy can result in neonatal opioid withdrawal syndrome after birth. Pregnant patients should discuss opioid treatment with their healthcare professional rather than stopping suddenly. 

Patients should seek emergency medical attention for very slow or stopped breathing, inability to wake the person, severe confusion, loss of consciousness, or suspected overdose. Naloxone can rapidly reverse opioid overdose and may be recommended for patients or households at increased risk of opioid overdose.

Key Insights 

Laurelton, N.Y. Epic Pharma, LLC has launched Hydrocodone Bitartrate & Acetaminophen Tablets, the generic equivalent of Norco. This opioid analgesic is indicated to relieve moderate to moderately severe pain. It is available in 5 mg/325 mg, 7.5 mg/325 mg, and 10 mg/325 mg strengths, packaged in 100-count bottles.